Want to join the conversation?
Specialty pharmaceutical company $VRX said the Dermatologic and Ophthalmic Drugs Advisory Committee appointed by the US FDA has voted by 18 to 0 to brodalumab injection, 210 mg, for adult patients with moderate-to-severe plaque psoriasis. FDA will consider this recommendation in its review of the Biologics License Applications for brodalumab.
$AVGO 4Q results beat analyst’s expectations again this time. Time to make some hay while the sun shines ;)
You are such a letdown $FII. I regret not selling you when you were nearing $33. Now I am stuck with you, you are stuck with me!
Can you imagine a food store with no cash registers? Well, it is coming true soon thanks to $AMZN. The company is opening its new grocery store in Seattle and it has no cash registers. AI takes over!